Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Oct;43(10):1027-33.
doi: 10.1007/s11033-016-4040-9. Epub 2016 Jul 12.

Expression of metalloproteinases (MMP-2 and MMP-9) in basal-cell carcinoma

Affiliations
Free PMC article

Expression of metalloproteinases (MMP-2 and MMP-9) in basal-cell carcinoma

Anna Goździalska et al. Mol Biol Rep. 2016 Oct.
Free PMC article

Abstract

The aim of this study was to compare the expressions of mRNA for metalloproteinases (MMP-2 and MMP-9) and type IV collagen in two different histological types of basal-cell carcinoma (BCCs; nodular and infiltrative) and in normal tissues from the tumor interface. The study included biopsy specimens of the skin involved with BCC and normal skin adjacent the lesion. The expressions of mRNA for MMP-2, MMP-9 and type IV collagen were determined by means of RT-PCR (Reverse transcription polymerase chain reaction). The level of type IV collagen mRNA in nodular and infiltrative BCCs turned out to be significantly lower, and the expressions of MMP-2 and MMP-9 mRNA significantly higher than in normal tissues adjacent to these tumors. The expression of mRNA for MMP-9 but not for MMP-2 was significantly higher in infiltrative BCCs than in the nodular BCCs. In turn, normal tissues adjacent to nodular BCCs showed significantly higher levels of mRNA for MMP-2 and significantly lower levels of type IV collagen mRNA than the normal tissues from the interface of infiltrative BCCs. The findings suggest that MMP-2 and MMP-9 could be used as prognostic factors of BCCs.

Keywords: Basal-cell carcinoma; Invasiveness; Matrix metalloproteinases; Molecular diagnosis; Resection margin; Type IV collagen.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Mean (±SD) expressions of mRNA for type IV collagen in the tissues (T) of nodular (nBCC) and infiltrative (iBCC) basal-cell carcinoma and in normal tissues adjacent to the tumors (NT)
Fig. 2
Fig. 2
Mean (±SD) expressions of mRNA for matrix metalloproteinases 2 (MMP2) and 9 (MMP9) in the tissues (T) of nodular (nBCC) and infiltrative (iBCC) basal-cell carcinoma and in normal tissues adjacent to the tumors (NT)

Similar articles

Cited by

References

    1. Kułakowski A, Skowrońska-Gardas A. Onkologia. Warszawa: PZWL; 2007.
    1. Kumar V, Cotran R, Robbins S. Patologia. Wrocław: Urban Partner; 2005.
    1. Stachura J, Domagała W. Patologia znaczy słowo o chorobie. Warszawa: PZWL; 2008.
    1. Chicheł A, Skowronek J. Contemporary management of skin cancer–dermatology, surgery or radiotherapy? Contemp Oncol. 2005;9(10):429–435.
    1. Cumberland L, Dana A, Liegeois N. Mohs micrographic surgery for the management of nonmelanoma skin cancers. Facial Plast Surg Clin North Am. 2009;17(3):325–335. doi: 10.1016/j.fsc.2009.06.001. - DOI - PubMed